Molnupiravir is an oral, small-molecule antiviral prodrug that is active against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
VANCOUVER, BC, January 04, 2022 /24-7PressRelease/ — SaveRxCanada.to, the premier Canadian pharmacy intermediary since 2002 announces that it has added generic Lagevrio (Molnupiravir) to its International Generic Program.
Under the International Generic Program, this prescription drug is available from India (Natco Pharma) and is marketed as Molnunat. Free shipping is available for ordering this product.
How Effective is Molnupiravir?
In the New England Journal of Medicine study “Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients”, they conducted a phase 3, double-blind, randomized, placebo-controlled trial to evaluate the efficacy and safety of treatment with molnupiravir started within 5 days after the onset of signs or symptoms in nonhospitalized, unvaccinated adults with mild-to-moderate, laboratory-confirmed Covid-19 and at least one risk factor for severe COVID-19 illness.
A total of 1433 participants underwent randomization; 716 were assigned to receive molnupiravir and 717 to receive placebo. The study concluded that early treatment with molnupiravir reduced the risk of hospitalization or death in at-risk, unvaccinated adults with COVID-19. (1)
SaveRxCanada.to understands new treatments are needed to reduce the risk of progression of coronavirus disease and adding Molnupiravir is another treatment options for patients. Their International Generic Program provides larger savings to patients who are in need of lower cost alternatives.
SaveRxCanada.to is a health care product and services company located in Canada. Its main goal for the last 20 years has been to provide international clients access to low cost prescription medications. Many worldwide have been paying too much for their medications and SaveRxCanada.to has changed that. The company coordinates a network of pharmacies across the globe through which prescription drug orders are filled at the lower international prices.
All products are dispensed and/or shipped by licensed international pharmacies or fulfillment centers located in countries including, but not limited to, India, Singapore, Mauritius, Germany, UK, Turkey, Australia and New Zealand that are approved by regulatory authorities in their respective countries.
For more information, visit https://www.saverxcanada.to or call 1-866-799-3435 – Use ref #100048
1 – Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients – https://pubmed.ncbi.nlm.nih.gov/34914868/
For the original version of this press release, please visit 24-7PressRelease.com here